Allergen immunotherapy is a cornerstone in the treatment of allergic children. The clinical
efficiency relies on a well‐defined immunologic mechanism promoting regulatory T cells and …

Allergy is a major public health problem with a high socio‐economic impact. The number of
allergic patients is expected to reach to four billion within two decades when the World's …

Hymenoptera venom allergy is a potentially life‐threatening allergic reaction following a
honeybee, vespid, or ant sting. Systemic‐allergic sting reactions have been reported in up to …

Pneumologists, Sleep and Respiratory Physicians (BdP)(Sebastian Böing), Professional
Association of German Dermatologists (BVDD)(Klaus Strömer) were taking part in the …

Allergic diseases are common and frequently coexist. Allergen immunotherapy (AIT) is a
disease‐modifying treatment for IgE‐mediated allergic disease with effects beyond …

The current COVID-19 pandemic influences many areas of social life, medical treatments
and the way allergy diagnosis and treatment is performed. Allergen-specific immunotherapy …

Honeybee venom is a source of proteins with allergenic properties which can result in in
various symptoms, ranging from local reactions through to systematic life-threatening …

Hymenoptera stings may cause both local and systemic allergic reactions and even life
threatening anaphylaxis. Along with pharmaceutical drugs and foods, hymenoptera venom …

The seventh “Future of the Allergists and Specific Immunotherapy (FASIT)” workshop held in
2019 provided a platform for global experts from academia, allergy clinics, regulatory …

Regulatory approaches for allergen immunotherapy (AIT) products and the availability of
high‐quality AIT products are inherently linked to each other. While allergen products are …